Expression of the membrane complement regulatory proteins (CD55 and CD59) in human thymus

Folia Histochemica et Cytobiologica

Volumn 44, Issue 4, 2006, Pages 263-267

  Śladowski, Dariusz ^a,b   Wasiutyński, Aleksander ^a   Wilczyński, Grzegorz ^a   Grabska Liberek, Iwona ^a   Coecke, Sandra ^b   Kinsner, Agnieszka ^b   Kochanowska, Iwona ^c  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b JOINT RESEARCH CENTRE   (Italy)

^c INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Apoptosis; CD30L; CD55; CD59; Clone selection; Complement; Hassall's corpuscles; Immunohistochemistry

Indexed keywords

CD30 ANTIGEN; CD59 ANTIGEN; DECAY ACCELERATING FACTOR; TUMOR NECROSIS FACTOR;

ADOLESCENT; APOPTOSIS; ARTICLE; CELL PROTECTION; CELLULAR DISTRIBUTION; CHILD; COMPLEMENT SYSTEM; CORRELATION ANALYSIS; EPITHELIUM CELL; FETUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; NICK END LABELING; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; THYMUS;

PRIMATES; SUS SCROFA;

EID: 33750716528     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Akami T, Arakawa K, Okamoto M, Sawada R, Naruto M, Oka T (1993) The role of human CD59 antigen in discordant xenotransplantation between humans and nonprimates. Transplant Proc 25: 394-395
2. Akatsu H, Yamada T, Okada N, Yamamoto T, Yamashina M, Okada H (1997) Unique expression of HRF20 (CD59) in human nervous tissue. Microbiol Immunol 41: 321-329
3. Aries SP, Schaaf B, Hansen F, Weyrich K, Kurowski V, Dennin R, Dalhoff K (1997) Expression of complement receptors and regulatory proteins on alveolar CD4+ lymphocytes from human immunodeficiency virus-1 infected individuals. Eur Respir J 10: 1736-1741
4. Brelinska R, Jaroszewicz A, Kowaiska K (2002) Age-related changes in rat thymic epithelial cells. Folia Histochem Cytobiol 40: 173-174
5. Brelinska R, Ostalska D, Paczkowska A, Jaroszewski J (2001) Histogenesis of the rat thymic medulla during first stages of development. Folia Histochem Cytobiol 39: 197-198
6. Brelinska R, Ostalska D, Kaczmarek E, Kowalska K (2002) Stages of the rat thymic medulla development in foetal period. Folia Histochem Cytobiol 40: 171-172
7. Charreau B, Cassard A, Tesson L, Le Mauff B, Blanchard D, Lublin D, Soulillou JP, Anegon I (1994) Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor. Transplantation 58: 1222-1229
8. Chen RH, Naficy S, Logan JS, Diamond LE, Adams DH (1999) Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates. Xenotransplantation 6: 194-200
9. Chen S, Chen G, Cai CC, Wang XM, Guo H, Shen SQ, Wang H, Wu Y, Li GX, Huang J, Li WX, Wei QX, Sun FZ (2001) A study of human DAF, CD59, MCP transgene in xenotransplantation. Transplant Proc 33: 3851-3852
10. Dave SJ, Sodetz JM (1990) Regulation of the membrane attack complex of complement. Evidence that C8 gamma is not the target of homologous restriction factors. J Immunol 144: 3087-3090
11. Deckert M, Ticchioni M, Mari B, Mary D, Bernard A (1995) The glycosylphosphatidylinositol-anchored CD59 protein stimulates both T cell receptor zeta/ZAP-70-dependent and - independent signaling pathways in T cells. Eur J Immunol 25: 1815-1822
12. Diamond LE, McCurry KR, Oldham ER, Tone M, Waldmann H, Platt JL, Logan JS (1995) Human CD59 expressed in transgenic mouse hearts inhibits the activation of complement. Transpl Immunol 3: 305-312
13. French LE, Sappino AP, Tschopp J, Schifferli JA (1992) Distinct sites of production and deposition of the putative cell death marker clusterin in the human thymus. J Clin Invest 90: 1919-1925
14. French LE, Sappino AP, Tschopp J, Schifferli JA (1994) Clusterin gene expression in the rat thymus is not modulated by dexamethasone treatment. Immunology 82: 328-331
15. Golay J, Zaffaroni L, Vaccari T, Lazzari M, Borleri GM, Bernasconi S, Tedesco F, Rambaldi A, Introna M (2000) Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis. Blood 95: 3900-3908
16. Gorter A, Meri S (1999) Immune evasion of tumor cells using membrane-bound complement regulatory proteins. Immunol Today 20: 576-582
17. Guc D, Canpinar H, Kucukaksu C, Kansu E (2000) Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies. Eur J Haematol 64: 3-9
18. Hayashi S, Isobe K, Emi N, Yokoyama I, Takagi H (1994) Inhibition of species-specific complement-mediated cytolysis in xenoendothelial cells transfected with GPI-anchored complement regulatory factor (DAF, HRF20) gene using retroviral vector: comparison between single (DAF or HRF20) and double (DAF and HRF20) transfected xenoendothelial cells. Transplant Proc 26: 1243-1244
19. Hess KL, Tudor KS, Johnson JD, Osati-Ashtiani F, Askew DS, Cook-Mills JM (1997) Human and murine high endothelial venule cells phagocytose apoptotic leukocytes. Exp Cell Res 236: 404-411
20. Hideshima T, Okada N, Okada H (1990) Expression of HRF20, a regulatory molecule of complement activation, on peripheral blood mononuclear cells. Immunology 69: 396-401
21. Holmes CH, Simpson KL, Okada H, Okada N, Wainwright SD, Purcell DF, Houlihan JM (1992) Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55). Eur J Immunol 22: 1579-1585
22. Jensen TS, Bjorge L, Wollen AL, Ulstein M (1995) Identification of the complement regulatory proteins CD46, CD55, and CD59 in human fallopian tube, endometrium, and cervical mucosa and secretion. Am J Reprod Immunol 34: 1-9
23. Jiang H, Pillai S (1998) Complement regulatory proteins on the sperm surface: relevance to sperm motility. Am J Reprod Immunol 39: 243-248
24. Jones J, Morgan BP (1995) Apoptosis is associated with reduced expression of complement regulatory molecules, adhesion molecules and other receptors on polymorphonuclear leucocytes: functional relevance and role in inflammation. Immunology 86: 651-660
25. Koch-Brandt C, Morgans C (1996) Clusterin: a role in cell survival in the face of apoptosis? Prog Mol Subcell Biol 16: 130-149
26. Kroshus TJ, Bolman RM III, Dalmasso AP, Rollins SA, Guilmette ER, Williams BL, Squinto SP, Fodor WL (1996) Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model. Transplantation 61: 1513-1521
27. Kulick DM, Salerno CT, Dalmasso AP, Park SJ, Paz MG, Fodor WL, Bolman RM III (2000) Transgenic swine lungs expressing human CD59 are protected from injury in a pig-to-human model of xenotransplantation. J Thorac Cardiovasc Surg 119: 690-699
28. Kunii H, Shichishima T, Saitoh Y, Noji H, Maruyama Y (1998) Surface expression of complement regulatory proteins, decay-accelerating factor (DAF) and CD59, on cultured human endothelial cells. Fukushima J Med Sci 44: 69-81
29. Lavitrano M, Frati L (1999) Xenotransplantation: state of the art. Forum (Genova) 9: 74-83
30. Maio M, Brasoveanu LI, Coral S, Sigalotti L, Lamaj E, Gasparollo A, Visintin A, Altomonte M, Fonsatti E (1998) Structure, distribution, and functional role of protectin (CD59) in complement-susceptibility and in immunotherapy of human malignancies. Int J Oncol 13: 305-318
31. Medof ME, Kinoshita T, Silber R, Nussenzweig V (1985) Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor. Proc Natl Acad Sci USA 82: 2980-2984
32. Meri S, Waldmann H, Lachmann PJ (1991) Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissues. Lab Invest 65: 532-537
33. Meri S, Morgan BP, Davies A, Daniels RH, Olavesen MG, Waldmann H, Lachmann PJ (1990) Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology 71: 1-9
34. Michetti F (1980) Antigenic properties of the loosely bound subnuclear fraction of rat brain. Neurochem Res 5: 731-743
35. Miyagawa S, Shirakura R, Matsumiya G, Nakata S, Matsuda H, Hatanaka M, Matsumoto M, Seya T (1994) Possibility of prevention of hyperacute rejection by DAF and CD59 in xenotransplantation. Transplant Proc 26: 1235-1238
36. Nose M, Katoh M, Okada N, Kyogoku M, Okada H (1990) Tissue distribution of HRF20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression on endothelial cells in vivo. Immunology 70: 145-149
37. Oglesby TJ, Longwith JE, Huettner PC (1996) Human complement regulator expression by the normal female reproductive tract. Anat Rec 246: 78-86
38. Ors U, Dagdeviren A, Kaymaz FF, Muftuoglu SF (1999) Cysts in human thymus: maturational forms of Hassal's corpuscles? Okajimas Folia Anat Jpn 76: 61-69
39. Ostalska D, Brelinska R, Jaroszewski J (1999) Pattern of cytokeratin 8 expression in the developing rat thymus. Folia Histochem Cytobiol 37: 159-160
40. Park JH, Park JS, Ju SK, Lee KB, Park YK, Kang MH, Na SY, You KH (2003) Clusterin mRNA expression in apoptotic and activated rat thymocytes. Cell Res 13: 49-58
41. Romagnani P, Annunziato F, Manetti R, Mavilia C, Lasagni L, Manuelli C, Vannelli GB, Vanini V, Maggi E, Pupilli C, Romagnani S (1998) High CD30 ligand expression by epithelial cells and Hassal's corpuscles in the medulla of human thymus. Blood 91: 3323-3332
42. Simpson KL, Houlihan JM, Holmes CH (1993) Complement regulatory proteins in early human fetal life: CD59, membrane co-factor protein (MCP) and decay-accelerating factor (DAF) are differentially expressed in the developing liver. Immunology 80: 183-190
43. Stryjski R, Warchol JB, Brelinska R, Jaroszewski J (1992) Analysis of thymocyte contacts with other thymic cells. Folia Histochem Cytobiol 30: 57-62
44. Treon SP, Mitsiades C, Mitsiades N, Young G, Doss D, Schlossman R, Anderson KC (2001) Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies. J Immunother 24: 263-271
45. Tschopp J, Chonn A, Hertig S, French LE (1993) Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9. J Immunol 151: 2159-2165
46. Tsunoda S, Kawano M, Koni I, Kasahara Y, Yachie A, Miyawaki T, Seki H (2000) Diminished expression of CD59 on activated CD8+ T cells undergoing apoptosis in systemic lupus erythematosus and Sjogren's syndrome. Scand J Immunol 51: 293-299
47. Varsano S, Frolkis I, Ophir D (1995) Expression and distribution of cell-membrane complement regulatory glycoproteins along the human respiratory tract. Am J Respir Crit Care Med 152: 1087-1093
48. Weichenthal M, Siemann U, Neuber K, Breitbart EW (1999) Expression of complement regulatory proteins in primary and metastatic malignant melanoma. J Cutan Pathol 26: 217-221